Role of sphingolipids in oestrogen signalling in breast cancer cells: an update.

Abstract

The signaling pathways activated by the steroid hormone oestrogen include a variety of cytoplasmic second messengers linked to a multitude of tissue-specific effects. In the last decade, sphingolipids and their membrane receptors were added to the list of oestrogen-activated mediators. Oestrogen triggers the sphingolipid signalling cascade in various tissues including breast cancer. Extensive research has shown that sphingolipids are the key regulatory molecules in growth factor networks. Sphingolipids can control the rate of cell proliferation and the differentiation outcome during malignant transformation. In this study, we summarise novel experimental evidences linking sphingolipids to oestrogen-activated effects, highlight the role of sphingolipids in cancer cells and discuss new avenues for future research at the intersection between oestrogen and sphingolipid signalling.

• Authors: O Sukocheva, C Wadham
• Journal: The Journal of endocrinology (J Endocrinol) Vol. 220 Issue 3 Pg. R25-35 (Mar 2014) ISSN: 1479-6805 [Electronic] England
• PMID: 24323911 (Publication Type: Journal Article, Review)

Chemical References

• Estrogens
• Sphingolipids

Topics

• Animals
• Breast Neoplasms (genetics, metabolism)
• Estrogens (metabolism)
• Female
• Humans
• Signal Transduction
• Sphingolipids (metabolism)